Medicare Enrolled

Dr. Sarah Wang, M.D.

Hematology & Oncology · Tyler, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
501 SAUNDERS AVE STE 300, Tyler, TX 75702
9035799800
In practice since 2011 (14 years)
NPI: 1841581931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Sarah Wang is a hematology & oncology in Tyler, TX, with 14 years in practice. Based on federal Medicare data, Dr. Wang performed 553 Medicare services across 403 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wang received a total of $42,278 from 65 pharmaceutical and/or device companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ 553 Medicare services$ $42,278 industry payments

Medicare Practice Summary

Medicare Utilization ↗
553
Medicare services
Bottom 35% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
403
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~40 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)172$125$258
Blood draw (venipuncture)44$8$20
Complete blood count (CBC) with differential42$8$36
New patient office visit, complex (60-74 min)41$165$559
Office visit, established patient (30-39 min)40$84$232
Comprehensive metabolic blood panel38$10$64
Hospital follow-up visit, high complexity23$91$194
Initial hospital admission, high complexity22$131$368
Initial hospital admission, moderate complexity21$94$256
Hospital follow-up visit, moderate complexity20$60$140
Iron level test18$6$27
Iron binding capacity test18$9$35
Ferritin level test (iron stores)16$13$60
Vitamin B-12 level test14$15$76
New patient office visit (45-59 min)13$129$525
Lactate dehydrogenase (enzyme) level11$6$31
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$42,278
Total received (2018-2024)
Avg $6,040/year across 7 years
Top 14% in TX for hematology & oncology
65
Companies
328
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,801 (75.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,871 (23.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$606 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,872
2023
$9,758
2022
$11,844
2021
$3,026
2020
$142
2019
$2,404
2018
$232

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$8,859
Daiichi Sankyo Inc.
$7,164
Merck Sharp & Dohme LLC
$5,843
Genentech USA, Inc.
$2,508
Coherus Biosciences Inc.
$2,321
EMD Serono, Inc.
$2,212
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,163
E.R. Squibb & Sons, L.L.C.
$2,011
AstraZeneca UK Limited
$1,182
Amgen Inc.
$837
Janssen Biotech, Inc.
$634
Regeneron Healthcare Solutions, Inc.
$475
Foundation Medicine, Inc.
$401
GENZYME CORPORATION
$332
GlaxoSmithKline, LLC.
$303
ABBVIE INC.
$272
Merck Sharp & Dohme Corporation
$267
G1 Therapeutics, Inc.
$244
Agios Pharmaceuticals, Inc.
$233
Janssen Scientific Affairs, LLC
$224
Kite Pharma, Inc.
$220
BeiGene USA, Inc.
$210
Tempus AI, Inc
$200
Astellas Pharma US Inc
$191
Pharmacyclics LLC, An AbbVie Company
$178
SOBI, INC
$175
Medtronic, Inc.
$160
Pharmacyclics LLC, an AbbVie Company
$152
Karyopharm Therapeutics Inc.
$151
Genmab U.S., Inc.
$144
PFIZER INC.
$144
JAZZ PHARMACEUTICALS INC.
$137
AbbVie Inc.
$131
Janssen Pharmaceuticals, Inc
$124
Rigel Pharmaceuticals, Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$112
Novartis Pharmaceuticals Corporation
$104
TAIHO ONCOLOGY, INC.
$93
Emmaus Medical, Inc.
$91
Blueprint Medicines Corporation
$90
Bayer HealthCare Pharmaceuticals Inc.
$85
Alexion Pharmaceuticals, Inc.
$85
TG Therapeutics, Inc.
$83
Ipsen Biopharmaceuticals, Inc
$72
Celgene Corporation
$57
Eisai Inc.
$50
Stemline Therapeutics Inc.
$45
Jazz Pharmaceuticals Inc.
$44
Lilly USA, LLC
$42
Incyte Corporation
$37
ARRAY BIOPHARMA INC
$30
Aveo Pharmaceuticals, Inc.
$28
Shionogi Inc
$27
Seagen Inc.
$23
Iovance Biotherapeutics, Inc.
$17
Adaptive Biotechnologies Corporation
$17
Bayer Healthcare Pharmaceuticals Inc.
$15
Taiho Oncology, Inc.
$15
Acrotech Biopharma LLC
$14
AbbVie, Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$13
Exelixis Inc.
$13
Clovis Oncology, Inc.
$13
EISAI INC.
$12
Kyowa Kirin, Inc.
$12
Top 3 companies account for 51.7% of total payments
Associated products mentioned in payments ›
AYVAKIT · Abraxane · Alecensa · Amtagvi · Aranesp · BALVERSA · BELEODAQ · BOSULIF · BRUKINSA · CALQUENCE · CARVYKTI · COSELA · CREON · Cabometyx · DARZALEX · DOPTELET · ELREXFIO · EPKINLY · EXKIVITY · Endari · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · GILOTRIF · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · Mulpleta · Neulasta · Nplate · OJJAARA · OPDIVO · Orserdu · PYRUKYND · Padcev · Pomalyst · RYBREVANT · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SIGNIA · SOMATULINE DEPOT · Stivarga · TAGRISSO · TECENTRIQ · TECVAYLI · TEPMETKO · TUKYSA · Tecentriq · UKONIQ · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vitrakvi · XALKORI · XARELTO · XPOVIO · XT CDX · Xospata · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $7,645 per 100 Medicare services performed
Looking for a hematology & oncology in Tyler?
Compare hematology & oncologys in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
10
Per 100K population
4.2
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wang is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 14%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wang experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wang performed 172 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $42,278 from 65 companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other hematology & oncologys in Tyler?
Dr. Wang's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →